Literature DB >> 6598970

Plasma nicotine concentrations from repeated doses of nasal nicotine solution.

R J West, M J Jarvis, M A Russell, C Feyerabend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6598970     DOI： 10.1111/j.1360-0443.1984.tb03894.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN： 0952-0481


× No keyword cloud information.
  6 in total

1.  Nasal nicotine spray: a rapid nicotine delivery system.

Authors:  G Sutherland; M A Russell; J Stapleton; C Feyerabend; O Ferno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Absolute bioavailability of nicotine applied to different nasal regions.

Authors:  C J Johansson; P Olsson; M Bende; T Carlsson; P O Gunnarsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.

Authors:  N G Schneider; E Lunell; R E Olmstead; K O Fagerström
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

4.  Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray.

Authors:  Kenneth A Perkins; Joshua L Karelitz; Margaret C Boldry
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

Review 5.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 6.  Risk-benefit assessment of nicotine preparations in smoking cessation.

Authors:  J R Hughes
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.